Researchers have been able to identify at least three distinct subtypes of a rare type of bone cancer for the first time, which could transform clinical trials and patient care. While genetic ...
Large-scale analysis of patient cohorts reveals a novel mechanism driving osteosarcoma, an aggressive paediatric bone cancer. The researchers show that this mechanism occurs in approximately 50% of ...
SARC041: A phase 3 randomized double-blind study of abemaciclib versus placebo in patients with advanced dedifferentiated liposarcoma. Phase 1 dose-expansion study of oral TP-1287, a cyclin-dependent ...
Research collaboration: ICGC Bone Cancer Project: Osteosarcoma/Chondrosarcoma/Rare Subtypes is a research collaboration whose article contributions are accrued to its ...
MI-Common Data Model: Extending Observational Medical Outcomes Partnership-Common Data Model (OMOP-CDM) for Registering Medical Imaging Metadata and Subsequent Curation Processes The Osteosarcoma ...
New interdisciplinary research is exploring the probability of tumors metastasizing, or spreading in patients with osteosarcoma, a bone cancer in which children and adolescents make up approximately ...
A major driver of the bone cancer osteosarcoma has been discovered by researchers from UCL, EMBL EBI and the Royal National Orthopaedic Hospital, providing insights that could help to predict cancer ...
Osteosarcoma is the earliest identified hominin cancer. It was found in a 1.7-million-year-old hominin fossil in South Africa and has also been identified in a 77-million-year-old dinosaur specimen. 1 ...
BARNARD, VT / ACCESS Newswire / May 1, 2026 / For nearly 50 years, treatment options for osteosarcoma, a rare form of bone cancer that primarily affects children and young adults, have seen little ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results